Abstract
CD40 ligand (CD40L, CD154), a transmembrane protein structurally related to the cytokine TNF-α, was originally identified on stimulated CD4+ T cells1,2,3, and later on stimulated mast cells and basophils4. Interaction of CD40L on T cells with CD40 on B cells is of paramount importance for the development and function of the humoral immune system5. CD40 is not only constitutively present on B cells, but it is also found on monocytes, macrophages and endothelial cells, suggesting that CD40L has a broader function in vivo. We now report that platelets express CD40L within seconds of activation in vitro and in the process of thrombus formation in vivo. Like TNF-α and interleukin-1, CD40L on platelets induces endothelial cells to secrete chemokines and to express adhesion molecules, thereby generating signals for the recruitment and extravasation of leukocytes at the site of injury. Our results indicate that platelets are not only involved in haemostasis but that they also directly initiate an inflammatory response of the vessel wall.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Armitage, R. J. et al. Molecular and biological characterization of a murine ligand for CD40. Nature 357, 80–82 (1992).
Graf, D., Korthäuer, U., Mages, H. W., Senger, G. & Kroczek, R. A. Cloning of TRAP, a ligand for CD40 on human T cells. Eur. J. Immunol. 22, 3191–3194 (1992).
Lederman, S. et al. Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help). J. Exp. Med. 175, 1091–1101 (1992).
Gauchat, J. F. et al. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 365, 340–343 (1993).
Kroczek, R. A. et al. Defective expression of CD40 ligand on T cells causes X-linked immunodeficiency with hyper-IgM (HIGM1)”. Immunol. Rev. 138, 39–59 (1994).
Nieuwenhuis, H. K., van Oosterhout, J. J., Rozemuller, E., van Iwaarden, F. & Sixma, J. J. Studies with a monoclonal antibody against activated platelets: evidence that a secreted 53,000-molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulation. Blood 70, 838–845 (1987).
Holmsen, H. in Hemostasis and Thrombosis (eds Colman, R. W., Hirsh, J., Marder, V. J. & Salzman, E. W.) 3rd edn, 524–545 (Lippincott, Philadelphia, 1994).
Graf, D. et al. Asoluble form of TRAP (CD40 ligand) is rapidly released after T cell activation. Eur. J. Immunol. 25, 1749–1754 (1995).
Lauffer, L. et al. Monomeric and dimeric forms of soluble receptors can differ in their neutralization potential. Behring Inst. Mitt. 96, 21–31 (1995).
Yellin, M. J. et al. Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals. J. Exp. Med. 182, 1857–1864 (1995).
Hollenbaugh, D. et al. Expression of functional CD40 by vascular endothelial cells. J. Exp. Med. 182, 33–40 (1995).
Karmann, K., Hughes, C. C., Schechner, J., Fanslow, W. C. & Pober, J. S. CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc. Natl Acad. Sci. USA 92, 4342–4346 (1995).
Springer, T. A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76, 301–314 (1994).
Bevilacqua, M. P. Endothelial-leukocyte adhesion molecules. Annu. Rev. Immunol. 11, 767–804 (1993).
Ebnet, K., Kaldjian, E. P., Anderson, A. O. & Shaw, S. Orchestrated information transfer underlying leukocyte endothelial interactions. Annu. Rev. Immunol. 14, 155–177 (1996).
Baggiolini, M., Dewald, B. & Moser, B. Interleukin-8 and related chemotactic cytokines — CXC and CC chemokines. Adv. Immunol. 55, 97–178 (1994).
Ware, J. A. & Heistad, D. D. Platelet-endothelium interactions. N. Engl. J. Med. 328, 628–635 (1993).
Clark, R. A. F. in The Molecular and Cellular Biology of Wound Repair (ed. Clark, R. A. F.) 2nd edn, 3–50 (Plenum, New York, 1996).
Alderson, M. R. et al. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J. Exp. Med. 178, 669–674 (1993).
Caux, C. et al. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180, 1263–1272 (1994).
Kiener, P. A. et al. Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J. Immunol. 155, 4917–4925 (1995).
Hawrylowicz, C. M., Howells, G. L. & Feldman, M. Platelet-derived interleukin 1 induces human endothelial adhesion molecule expression and cytokine production. J. Exp. Med. 174, 785–790 (1991).
Kaplanski, G. et al. Activated platelets induce endothelial secretion of interleukin-8 in vitro via an interleukin-1-mediated event. Blood 81, 2492–2495 (1993).
Davies, M. J. The contribution of thrombosis to the clinical expression of coronary atherosclerosis. Thromb. Res. 82, 1–32 (1996).
Kenny, D., Newman, P. J., Morateck, P. A. & Montgomery, R. A. Adinucleotide deletion results in defective membrane anchoring and circulating soluble glycoprotein Ibα in a novel form of Bernard-Soulier syndrome. Blood 90, 2626–2633 (1997).
Cordell, J. L. et al. Immuno-enzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J. Histochem. Cytochem. 32, 219–229 (1984).
Korthäuer, U. et al. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361, 539–541 (1993).
Ogura, M. et al. Establishment of a novel human megakaryoblastic leukemia cell line, MEG-01, with positive Philadelphia chromosome. Blood 66, 1384–1392 (1985).
Komatsu, N. et al. Establishment and characterization of a human leukemic cell line with megakaryocytic features: dependency on granulocyte-macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival. Cancer Res. 51, 341–348 (1991).
Acknowledgements
J.R.S. is a postdoctoral fellow of the Max-Planck Society. We thank R. Kurrle for the generous gift of CD40-Ig, J. Schröder for ELISA reagents for determination of IL-8, and H.W. Mages for critically reading the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Henn, V., Slupsky, J., Gräfe, M. et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391, 591–594 (1998). https://doi.org/10.1038/35393
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/35393
This article is cited by
-
Predictive value of soluble CD40L combined with APACHE II score in elderly patients with sepsis in the emergency department
BMC Anesthesiology (2024)
-
Bariatric Surgery Improves Serum CD40L Levels as a Predictor of Cardiovascular Risk: Systematic Review and Meta-analysis
Obesity Surgery (2024)
-
Current concepts and novel targets for antiplatelet therapy
Nature Reviews Cardiology (2023)
-
Platelet factor 4 (PF4) induces cluster of differentiation 40 (CD40) expression in human aortic endothelial cells (HAECs) through the SIRT1/NF-κB/p65 signaling pathway
In Vitro Cellular & Developmental Biology - Animal (2023)
-
Thromboinflammatory challenges in stroke pathophysiology
Seminars in Immunopathology (2023)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.